• New CDC Infographic Shows 1 in 7 American Adults Now Have Chronic Kidney Disease
  • Mayo Clinic and Baxter to Partner on Therapies for Kidney Disease and Other Conditions
  • Most U.S. and European Doctors Want Therapies to Keep Diabetic Kidney Patients from Having to Go on Dialysis
  • Kidney Care Partners Applauds U.S. Bipartisan Legislation for Americans with CKD or End-stage Renal Disease
  • Resverlogix Welcomes Study Highlighting Apabetalone for CKD-Related Cardiovascular Disease
  • Avacopan Named Orphan Drug in Europe for Potential to Treat C3 Glomerulopathy
  • Obesity Is an Important CKD Risk Factor in Elderly People, Study Finds
  • FDA Approves Design of Phase 2a Trial of Apabetalone for Kidney Disease Patients on Dialysis
  • Vifor Pharma to Provide Akebia’s Anemia Therapy Vadadustat to Group of US Dialysis Clinics
  • Kidney Care Provider DaVita Is Taking Part in Mental Health Awareness Effort
  • Vitamin D Supplement’s Effects on Cardiovascular Mortality of CKD Patients Requires Further Research
  • Lupus-induced Kidney Damage Explained by Expert to Mark Lupus Awareness Month